Gemvax

A placebo-controlled study to evaluate the effect, safety and Efficacy of GV1001 in participants with mild to moderate AD.

To be eligible for this study, a potential participant must:

"*" indicates required fields

Step 1 of 3

Submit your interest to our team of specialists

Attention: Make sure to check that you fit the eligibility requirements.

First Name*

Last Name*

Email*

Phone Number*